Disease Landscape and Forecast Insights
Comprehensive market intelligence and actionable insights help you optimize your long-term disease strategy
Chronic Obstructive Pulmonary Disease | Treatment Algorithms | Claims Data Analysis | US | 2017
The COPD treatment algorithm continues to evolve, with changing recommendations on the use of ICS s, LABA / ICS FDC s, and LABA / LAMA FDC s. This study reveals which therapies are prescribed first…
Chronic Obstructive Pulmonary Disease | Disease Landscape and Forecast | G7 | 2016
The large therapeutic market for chronic obstructive pulmonary disease (COPD), a disease that is closely associated with smoking, continues to expand and is expected to grow from approximately $15…
Chronic Obstructive Pulmonary Disease | Treatment Algorithms | Claims Data Analysis | US | 2015
For the estimated 9 million patients diagnosed with chronic obstructive pulmonary disease (COPD) in the United States, there are multiple prescription therapies that are available for treating the…
Reimbursement and Pricing of Combination Products in the U.S. Asthma and COPD Markets
Increasing formulary competition and decreasing product differentiation have led to an aggressive pricing war in the U.S. asthma and chronic obstructive pulmonary disorder (COPD) markets. As…
How Will U.S. Physicians and Payers Respond to Additional LABA/LAMA FDCs in the Increasingly Crowded COPD Market? | Physician & Payer Forum | US | 2015
A Survey of Pulmonologists and Managed Care Organization Pharmacy and Medical Directors The U.S. market for chronic obstructive pulmonary disease (COPD) therapies consists entirely of…
